2008

Report Examines Cost-Effectiveness Of Larger...

Cardinal Health, Inc. Profit Beats Estimates,...

Genzyme And Isis Begin Second Phase 3 Trial...

Pooled-Analysis Of 54 Clinical Studies Shows...

Tolerx Initiates Dosing Of Otelixizumab, A...

SCOLR Pharma, Inc. Submits Abbreviated New...

Oramed Pharmaceuticals Announces Successful...

Mylan Inc. Posts Loss on Acquisition Items

Mylan reports loss despite much higher sales

Leukemia Journal Publishes Results From...

Boosted Reyataz And Lopinavir/R Achieve...

Cancer Researchers And Oncologists Offer A...

TMC278 Demonstrates Long-Term Efficacy And...

Pharmasset Reports Preliminary Results Of A...

Tolerx Announces Achievement Of Milestones...

Medarex Announces Allowance Of...

Cara Therapeutics Announces Successful...

Emisphere Announces Recruitment Of Novartis...

FDA Accepts Streamlined Phase 3 Development...

Ninety-Six Week Data On Tibotec...

Abbott's Kaletra(R) Tablet Dosed Once-Daily...

Bionor Immuno Advances HIV Peptide-Based...

Clinxus Partnership Devises Improved Tests To...

Argos Therapeutics' Arcelis Personalized...

New York Times Examines Research Efforts Into...

CVS, Rite Aid, IHOP Top Hot 100 Retailers...

Vitamin C Injections Slow Tumor Growth In...

Eating Fish May Prevent Memory Loss And...

Amicus Therapeutics Announces Successful...

Top-Line Results Of Boceprevir Phase II Study...

Single-Pill Combinations Diovan HCT And...

Monogram Biosciences Launches First...

Increase In Self-Esteem, Functionality Seen...

Karo Bio Announces Successful Phase II Study...

Electro-Optical Sciences Completes Patient...

Psychotic Symptoms Relieved With Estrogen...

Rectal Gel Could Limit HIV Transmission

KV Pharmaceutical's Motion for Rule 11...

David J. Mazzo, Ph.D., Joins Regado...

MDRNA Announces Phase 2 Trial Of PYY(3-36)...

Interferon Or Surgery For Eye Surface Cancer...

Turned-off Cannabinoid Receptor Turns On...

CVS posts record $774.8M profit for 2Q

Calcium Shown To Significantly Improve...

U.S. seizes unapproved medicines at KV...

Scientist make HIV breakthrough? - Zim...

HomeCARE II: BIOTRONIK Launches Clinical...

Tapes, Transcripts Might Help Cancer Patients...

RegeneRx Awarded Additional $136,000 From FDA...

BioMS Medical Completes Patient Recruitment...

In Elderly, Flu Vaccine Might Not Protect...

Liver Damage In Hepatitis C Patients Could Be...

U.S. FDA Issues Action Letter For Sugammadex

Allergic Like Reactions To Iodinated Contrast...

Creatine Supplementation Does Not Improve...

Diet, Exercise And Culturally Sensitive Care...

Cardinal Health steps in as Prime...

China Pharmaceutical Chain Industry Report,...

Neuropharma Reports Last Results On Its...

FDA Clears The Pathwork(R) Tissue Of Origin...

Preliminary Cerepro (R) Phase III Results...

Agents seize $24M worth of unapproved drugs...

FDA Clears The Pathwork(R) Tissue Of Origin...

New Data Highlights Positive Results Of...

DIABETES, DIET, CULTURALLY SENSITIVE CARE,...

Treatment Corrects Severe Insulin Imbalance...

Genmab And GlaxoSmithKline Announce Positive...

Aegera Initiates A Fifth Phase 1 And 2...

Study Reveals Novel LCD Solution Provides...

Poniard Pharmaceuticals To Present At The 4th...

Lab Study Shows Methadone Breaks Resistance...

AtheroGenics Reports Positive Results From...

LANI Phase II Completed -- Phase III...

Drug Has Potential To Prevent Alcoholics From...

Experts Continue To Cite Bifantis As...

FDA seizes unapproved drugs from St. Louis...

Bayer Names New U.S. CEO

Tapes, Transcripts Might Help Cancer Patients...

Zinc Could Saves Lives of Children With...

Results Of 9-Month Phase II Study Of...

Cochrane Review Evaluates Herbal Medicine...

Encouraging Results From Phase 2 Clinical...

Ongoing Phase II Study Explores Potential For...

Metabasis' Results From Its Phase 2a Clinical...

Inspire Provides Update On Cystic Fibrosis...

Long Acting Neuraminidase Inhibitor (LANI)...

Cody Labs gets license for imports

Quark Pharmaceuticals Announces First Patient...

Memory Pharmaceuticals Presents Positive...

Diverse Approaches To Alzheimer's Therapies...

Cadence Pharmaceuticals Announces FDA...

Phase II Data On Lilly's Antibody Show It...

First Ever Study On Alzheimer's Disease...

Anavex Presents Neuroprotective Effects Of...

New Data Highlight Positive Results Of...

DeCODE And SGENE Consortium Discover...

Peptimmune Announces Grant Of United States...

Nile Therapeutics Announces Dosing In Second...

GE Healthcare Announces Phase I Results With...

Innovative Approach To Management Of...

Elan, Wyeth Present Encouraging Bapineuzumab...

Trial Of New Drug For Alzheimer's Disease

Randomized Phase III Trial Comparing...

New Drug For HIV Treatment

Frankincense Provides Relief To Arthritis...

Federal Agents Seize more than $24 Million in...

Blazing her own trail, with cancer - Yellow...

Zacks Analyst Blog Highlights: Curtiss-Wright...

AAPM Cancer Research Highlights

Bayer's second-quarter net profit slips 13...

Zinc Could Saves Lives Of Children With...

Amendment For ELACYT Clinical Program...

ClinPhone Announces TrialWorks User Group...

ImQuest Receives Two Year Phase 2 SBIR Grant...

Idenix Pharmaceuticals Advances HCV Discovery...

FDA Advisory Committee Recommends Approval Of...

ICON Enhances Its ICOPhone Technology...

Vyteris Announces Successful Completion Of...

Titan Pharmaceuticals Announces Positive...

GTx Announces Phase III Clinical Development...

Nutra Pharma Announces Completion Of Clinical...

BRIDION(R) (sugammadex) Injection - First And...

A Hormone That Enhances One's Memory Of Happy...

McKesson Releases Preliminary Voting Results...

Zinc supplementation benefits children...

Doctors don't change their routine during...

Blacks Remain (Rightly) Wary of Medical...

Alleviating The Fear Of Falling

Controversy About Lack Of Placebo Group...

Vanda Pharmaceuticals Announces Receipt Of...

Statins May Protect Against Memory Loss

Drugs Commonly Used For Erectile Dysfunction...

Requiring Animal Research To Be More...

Infections In Brain Shunt Surgery Reduced By...

Mylan Positioning for Longer Term

Do Reading Materials for Health Professionals...

OctoPlus Proves Efficacy Of OP-145 In Phase...

European Legislation On Clinical Trials:...

Upstream Begins Animal Efficacy Testing For...

Researchers Analyze How New Anti-MRSA...

Polyphenon Pharma Receives Orphan Drug...

Two New Alzheimer's Disease Studies Show...

Ethanol Co-products Provide Means To Deliver...

Ardea To Present Data On Lead HIV Candidate,...

Exforge(R) Helps Nearly Twice As Many...

Nventa Announces Final Data From HspE7 Phase...

Electronic Brachytherapy Accurately Delivers...

Invasive Treatment Of Coronary Syndromes...

IMPAX Sued Based on ANDA Amendment for...

Lannett Company Granted Import License from...

Microsoft HealthVault and RelayHealth to...

Cornerstone Pharmaceuticals Announces...

Cephalon sues Barr Pharmaceuticals

Company officials charged in million-dollar...

Company officials charged in million-dollar...

Genaera Releases Phase 1 Data And New...

Anti-HIV Therapy Boosts Life Expectancy

Journal Of Clinical Oncology Article...

HIV Patients Are Living Longer Thanks To...

Fate of Barr Labs Pomona plant in limbo in...

Bioheart Reports Promising Results From SDF-1...

More Participants Sought For Study Of...

APOSENSE® [18F]-ML-10 For Molecular Imaging...

PharMerica Corporation Announces Results of...

Bentley Pharmaceuticals' Stockholders Approve...

Little Evidence That Treating Varicoceles in...

Research and Markets: Barr Pharma Partnering...

Scientists Suspect Omega 3 Fatty Acids Could...

Gilead Initiates Phase III Clinical Trial Of...

New HIV Drug Shows Viral Load Reduction In...

Dendreon Expects Interim Data Analysis For...

Topigen Completes Enrollment Of Phase II...